Literature DB >> 27122674

Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?

Behairy El-Sayed Behairy1, Mostafa Mohamed Sira1, Khaled Refat Zalata1, El-Sayed Ebrahem Salama1, Mohamed Ahmed Abd-Allah1.   

Abstract

AIM: To evaluate transient elastography (TE) as a noninvasive tool in staging liver fibrosis compared with liver biopsy and morphometry in children with different chronic liver diseases.
METHODS: A total of 90 children [50 with chronic hepatitis C virus (HCV), 20 with autoimmune hepatitis (AIH) and 20 with Wilson disease] were included in the study and underwent liver stiffness measurement (LSM) using TE. Liver biopsies were evaluated for fibrosis, qualitatively, by Ishak score and quantitatively by fibrosis area fraction (FAF) using digital image analysis (morphometry). LSM was correlated with fibrosis and other studied variables using spearman correlation. A stepwise multiple regression analysis was also performed to examine independent factors associated with LSM. Different cut-off values of LSM were calculated for predicting individual fibrosis stages using receiver-operating characteristic curve. Cut-off values with optimal clinical performance (optimal sensitivity and specificity simultaneously) were selected.
RESULTS: The majority of HCV group had minimal activity (80%) and no/mild fibrosis (72%). On the other hand, the majority of AIH group had mild to moderate activity (70%) and moderate to severe fibrosis (95%) and all Wilson disease group had mild to moderate activity (100%) and moderate to severe fibrosis (100%). LSM correlated significantly with both FAF and Ishak scores and the correlation appeared better with the latter (r = 0.839 vs 0.879, P < 0.0001 for both). LSM discriminated individual stages of fibrosis with high performance. Sensitivity ranged from 81.4% to 100% and specificity ranged from 75.0% to 97.2%. When we compared LSM values for the same stage of fibrosis, they varied according to the different etiologies. Higher values were in AIH (16.15 ± 7.23 kPa) compared to Wilson disease (8.30 ± 0.84 kPa) and HCV groups (7.43 ± 1.73 kPa). Multiple regression analysis revealed that Ishak fibrosis stage was the only independent variable associated with higher LSM (P < 0.0001).
CONCLUSION: TE appears reliable in distinguishing different stages of liver fibrosis in children. However, its values vary according to the disease type. For that, a disease-specific estimation of cut-off values for fibrosis staging is worthy.

Entities:  

Keywords:  Autoimmune hepatitis; Chronic hepatitis C; Liver fibrosis; Liver stiffness; Morphometry; Pediatrics; Transient elastography; Wilson disease

Mesh:

Year:  2016        PMID: 27122674      PMCID: PMC4837441          DOI: 10.3748/wjg.v22.i16.4238

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.

Authors:  Naim Alkhouri; Emad Sedki; Anna Alisi; Rocio Lopez; Massimo Pinzani; Ariel E Feldstein; Valerio Nobili
Journal:  Liver Int       Date:  2012-11-12       Impact factor: 5.828

3.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

4.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Authors:  Leon A Adams; Max Bulsara; Enrico Rossi; Bastiaan DeBoer; David Speers; Jacob George; James Kench; Geoffrey Farrell; Geoffrey W McCaughan; Gary P Jeffrey
Journal:  Clin Chem       Date:  2005-07-28       Impact factor: 8.327

6.  An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C.

Authors:  M J O'Brien; N M Keating; S Elderiny; S Cerda; A P Keaveny; N H Afdhal; D P Nunes
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

7.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

8.  Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.

Authors:  Victor de Lédinghen; Brigitte Le Bail; Laurent Rebouissoux; Céline Fournier; Juliette Foucher; Véronique Miette; Laurent Castéra; Laurent Sandrin; Wassil Merrouche; Frédéric Lavrand; Thierry Lamireau
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-10       Impact factor: 2.839

9.  Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods.

Authors:  Ahmed F Abdalla; Khaled R Zalata; Abeer F Ismail; Gamal Shiha; Mohamed Attiya; Ahmed Abo-Alyazeed
Journal:  Fibrogenesis Tissue Repair       Date:  2009-04-02

Review 10.  The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease.

Authors:  Julius Wilder; Keyur Patel
Journal:  Med Devices (Auckl)       Date:  2014-05-03
View more
  8 in total

Review 1.  Advances in diagnosis of chronic liver diseases in pediatric patients.

Authors:  Lucija Ruzman; Ivana Mikolasevic; Kristina Baraba Dekanic; Sandra Milic; Goran Palcevski
Journal:  World J Pediatr       Date:  2018-10-10       Impact factor: 2.764

2.  Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans.

Authors:  Martin Tibuakuu; Caroline Jjingo; Gregory Dale Kirk; David Lee Thomas; Ronald Gray; Victor Ssempijja; Fred Nalugoda; David Serwadda; Ponsiano Ocama; Christopher Kenneth Opio; David Erwin Kleiner; Thomas Charles Quinn; Steven James Reynolds
Journal:  J Viral Hepat       Date:  2020-06-09       Impact factor: 3.517

Review 3.  Ultrasound findings in autoimmune hepatitis.

Authors:  Yi Dong; Andrej Potthoff; Christoph Klinger; Ana Paula Barreiros; Dariusz Pietrawski; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

4.  Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments.

Authors:  Rosalia Ragusa; Liberato Simone Corsaro; Evelise Frazzetto; Emanuele Bertino; Maria Alessandra Bellia; Gaetano Bertino
Journal:  AJP Rep       Date:  2020-03-31

5.  Diagnostic Performance of Spin-Echo Echo-Planar Imaging Magnetic Resonance Elastography in 3T System for Noninvasive Assessment of Hepatic Fibrosis.

Authors:  Se Woo Kim; Jeong Min Lee; Sungeun Park; Ijin Joo; Jeong Hee Yoon; Won Chang; Haeryoung Kim
Journal:  Korean J Radiol       Date:  2022-01-04       Impact factor: 3.500

6.  Surveillance of Fontan-associated liver disease: current standards and a proposal from the European Society of Paediatric Radiology Abdominal Task Force.

Authors:  Giulia Perucca; Charlotte de Lange; Stéphanie Franchi-Abella; Marcello Napolitano; Michael Riccabona; Damjana Ključevšek; Seema Toso; Jochen Herrmann; Samuel Stafrace; Kassa Darge; Maria Beatrice Damasio; Costanza Bruno; Magdalena Maria Woźniak; Luisa Lobo; Donald Ibe; Anne M Smets; Philippe Petit; Lil-Sofie Ording Müller
Journal:  Pediatr Radiol       Date:  2021-10-15

7.  Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children.

Authors:  Penelope C Rose; Etienne D Nel; Mark F Cotton; Richard D Pitcher; Kennedy Otwombe; Sara H Browne; Steve Innes
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

Review 8.  Hepatitis C virus infection in children in the era of direct-acting antiviral.

Authors:  Malgorzata Pawlowska; Malgorzata Sobolewska-Pilarczyk; Krzysztof Domagalski
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.